Editas Medicine, Inc.
(NASDAQ : EDIT)

( )
EDIT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -6.73%146.810.0%$1534.10m
OCGNOcugen, Inc. -4.19%9.600.0%$1069.86m
NVAXNovavax, Inc. -14.27%205.9992.9%$909.19m
AMGNAmgen, Inc. -0.60%225.691.3%$548.32m
VRTXVertex Pharmaceuticals, Inc. 0.80%212.061.9%$521.91m
REGNRegeneron Pharmaceuticals, Inc. -1.77%454.862.7%$509.91m
ILMNIllumina, Inc. -1.23%441.013.5%$504.66m
GILDGilead Sciences, Inc. 0.88%63.011.0%$479.35m
ALXNAlexion Pharmaceuticals, Inc. -1.05%150.372.0%$354.39m
BNGOBionano Genomics, Inc. -3.66%9.480.0%$340.06m
BIIBBiogen, Inc. -1.24%269.851.7%$329.36m
CRSPCRISPR Therapeutics AG -0.37%129.770.6%$302.39m
EXASEXACT Sciences Corp. -2.72%136.3918.4%$253.67m
SGENSeagen Inc. 0.76%153.715.8%$214.53m
VXRTVaxart, Inc. -5.43%7.140.0%$189.51m

Company Profile

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.